Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • regulatory

    Headshot of Sarah Theobald with text reading 'Healthcare communications trends in 2026'

    What will healthcare communications look like in 2026? Amiculum’s prediction of upcoming trends

    By Sarah Theobald

    Amiculum

    Quote from the article: Without adapting JCA to include assessment of real-world data and broader benefits, vaccines may be undervalued

    Is Joint Clinical Assessment (JCA) appropriate for assessing the broader value of vaccines?

    By Emily Morton-West

    Amiculum

    - PMLiVE

    Lilly announces plan for new $3bn facility to boost manufacturing in Europe

    The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio

    - PMLiVE

    EU medicine shortages hit record highs in 2023 and 2024

    Even with countermeasures in place, European auditors warn that the risks remain elevated

    ECA webinar image

    ISPOR hosts expert webinar exploring the value of ECAs for regulatory and HTA evidence needs

    On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...

    Genesis Research Group

    Dave Miller on Biotechs image

    Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

    HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

    Genesis Research Group

    - PMLiVE

    Insights From ISPOR 2025: R In Health Technology Assessment – Is It The Future?

    ISPOR’s annual meeting in Montreal this May was packed with opportunities to explore the latest trends, insights, and research in HEOR and market access. In this series, our experts share...

    Petauri Evidence

    ISPOR partner seal

    Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

    Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural...

    Genesis Research Group

    - PMLiVE

    Your essential guide to the World EPA Congress 2025: Top sessions and pre-reading

    The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel sessions led by industry leaders driving market access strategy and practice. Following the opening keynote...

    Petauri Evidence

    - PMLiVE

    What does HEOR really mean in 2025?

    Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of people aged 60+ years is expected to soar. This both signals remarkable progress...

    Petauri Evidence

    Ispor Europe poster winning authors

    Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online

    Genesis Research Group's poster 'Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey' was recently named as...

    Genesis Research Group

    - PMLiVE

    Best practice RWE approaches to support economic modelling for HTA

    How can real-world evidence (RWE) support health technology assessment (HTA)? Join the live webinar on Thursday 3rd October at 1.00pm (BST), featuring panellists from Mtech Access, Arcturis, and Delta Hat.

    Petauri Evidence

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links